RENSSELAER, N.Y., April 20, 2018 -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology from the University of Nebraska.
Easi-CRISPR was developed in the laboratories of Drs. Masato Ohtsuka (Tokai University in Japan), and Channabasavaiah Gurumurthy (University of Nebraska). The terms of the agreement include a world-wide, non-exclusive license to the technology, allowing Taconic rights to generate and sell rodent models generated via Easi-CRISPR. When compared to traditional CRISPR, Easi-CRISPR represents a significant advantage, allowing researchers to perform whole genetic insertions versus being limited to point mutations and constitutive knockouts.
“Easi-CRISPR is the next progression of the revolutionary CRISPR/Cas technology. Combining the speed of CRISPR with larger genetic insertions allows complex projects typically requiring homologous recombination techniques to reduce project timelines by six months. In an industry where time is a precious resource, access to this technology underscores Taconic’s commitment to providing our customers with the best solutions,” shared John Couse, vice president of scientific services of Taconic Biosciences.
Channabasavaiah Gurumurthy commented, “we are pleased to see the research community quickly adopting Easi-CRISPR. Licensing of Easi-CRISPR by Taconic, a globally recognized leader of animal model generation, should help scientists rapidly generate innovative models to benefit scientific research”.
Taconic is a fully-licensed provider of rodent model generation services and has over twenty years of model design experience. The company provides gene inactivation, gene mutation or replacement, transgene expression, RNAi, and gene editing via CRISPR/Cas9, pronuclear injection, and homologous recombination technologies to ensure that the right tools are leveraged for each specific customer project. Taconic's unique capability of providing a seamless transition from model design to breeding and colony management, offers customers a complete solution. These scientific solutions include acquiring or generating, importing, licensing, breeding, testing, preparing, and distributing genetically engineered models to any location worldwide.
To learn more about Taconic’s custom model generation, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email [email protected].
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact:
Kelly Owen Grover
Director of Marketing Communications
(518) 697-3824
[email protected]


Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub 



